Thursday, August 21, 2014 10:33:25 PM
See here:
http://www.usatoday.com/story/news/nation/2014/08/21/ebola-us-patients-brantly-writebol-atlanta/14376997/
Now, what's really scary and could keep this thing going in Africa are: (1) continuing to eat bat and bush meat (the probable animal source of the virus); (2) continuing traditional burial practices for Ebola victims; (3) chasing out foreign aid workers with machetes; (4) thinking the whole thing (Ebola) is a Western hoax, and not keeping quarantine
http://www.breitbart.com/Big-Peace/2014/08/06/UN-Ebola-Outbreak-Likely-Caused-by-Bushmeat
http://www.washingtonpost.com/news/morning-mix/wp/2014/08/05/why-west-africans-keep-hunting-and-eating-bush-meat-despite-ebola-concerns/
http://www.voanews.com/content/traditional-burial-practices-hamper-efforts-to-fight-ebola/1970353.html
http://www.breitbart.com/Big-Peace/2014/07/29/Mob-Attacks-Violence-from-Villagers-Threatening-Ebola-Aid-Workers-in-Africa
http://www.newsweek.com/ebola-frontline-belief-ebola-hoax-causes-unrest-liberia-and-sierra-leone-265330
Ebola should burn out on its own, since (1) virus is only transmitted by fluids; (2) virus is only transmitted when patients show symptoms (or are dead); (3) virus is not airborn, and doesn't survive for long outside of a host
But overcoming the cultural things are the hardest.
I do agree Ebola will probably be around for a while the way things are going, and perhaps testing some experimental therapies might be possible for a while longer (6 months sounds right).
However, who thinks it will be feasible to run a trial when many of the people think the whole thing is a Western hoax, or chase foreign health / aid workers out of town with a machete?
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM